Research showed a higher risk for developing long COVID in women than men, with risk particularly notable in non-pregnant women and those aged 40 to 54 years.
A study found that lower-frequency doses of cephalexin were as effective as higher-frequency doses for treating cystitis, with similar clinical outcomes.
A study showed that patients’ lack of knowledge about antibiotic risks drives expectations for antibiotics in common illnesses, particularly in public clinics.